AMG 837: A potent, orally bioavailable GPR40 agonist

Jonathan B. Houze(Amgen (United States)), Liusheng Zhu(Amgen (United States)), Ying Sun(Amgen (United States)), Michelle Akerman(Amgen (United States)), Wei Qiu(Amgen (United States)), Alex J. Zhang(Amgen (United States)), Rajiv Sharma(Amgen (United States)), Michael Schmitt(Amgen (United States)), Yingcai Wang(Amgen (United States)), Jiwen Liu(Amgen (United States)), Jinqian Liu(Amgen (United States)), Julio C. Medina(Amgen (United States)), Jeff D. Reagan(Amgen (United States)), Jian Luo(Amgen (United States)), George Tonn(Amgen (United States)), Jane Zhang(Amgen (United States)), Jenny Ying-Lin Lu(Amgen (United States)), Michael Chen(Amgen (United States)), Edwin Lopez(Amgen (United States)), Kathy Nguyen(Amgen (United States)), Li Yang(Amgen (United States)), Liang Tang(Amgen (United States)), Hui Tian(Amgen (United States)), Steven J. Shuttleworth(Amgen (United States)), Daniel C.-H. Lin(Amgen (United States))
Bioorganic & Medicinal Chemistry Letters
November 7, 2011
10.1016/j.bmcl.2011.10.118
Cited by 130Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis